FORTE BIOSCIENCES
Forte Biosciences is a biotechnology company that focuses on dermatology. The company's lead product, FB-401, is a topically applied live biotherapeutic developed in collaboration with the National Institutes of Health and the National Institute of Allergy and Infectious Diseases for the treatment of inflammatory skin disease.
FORTE BIOSCIENCES
Industry:
Biotechnology Health Care Life Science Pharmaceutical
Founded:
2017-01-01
Address:
Sherman Oaks, California, United States
Country:
United States
Website Url:
http://www.fortebiorx.com
Total Employee:
51+
Status:
Active
Contact:
(858) 625-1025
Email Addresses:
[email protected]
Total Funding:
5.76 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Content Delivery Network Google Universal Analytics Microsoft Exchange Online Office 365 Mail
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Cambridge Science
Cambridge Science is a biotechnology company that focuses on scientific-technological innovation.
Dauntless Pharmaceuticals
Dauntless Pharmaceuticals is a biotechnology company that focuses on the development of drugs.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Designer Microbes
Designer Microbes is a biotechnology company that focuses on creating custom microbial strains.
Exotech Bio
Exotech Bio is a biotechnology platform.
Norak Biosciences
Norak Biosciences is a biotechnology company that uses proprietary technology for the discovery and development of drugs.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-02-20 | Tocagen | Tocagen acquired by Forte Biosciences | N/A |
Official Site Inspections
http://www.fortebiorx.com Semrush global rank: 4.93 M Semrush visits lastest month: 1.75 K
Unable to get host informations!!!
More informations about "Forte Biosciences"
Forte Biosciences Inc - About Us - Management - Board of Directors
Prior to joining AbbVie, Dr. Brun spent over 15 years at Abbott Laboratories, where he held positions of increasing leadership responsibility in drug development within the R&D …See details»
Forte Biosciences - Crunchbase Company Profile
Forte Biosciences is a biotechnology company that focuses on dermatology. The company's lead product, FB-401, is a topically applied live biotherapeutic …See details»
SEC.gov | HOME
Organization and Description of Business 1. Forte Biosciences, Inc. (www.fortebiorx.com), together with its subsidiaries, referred to herein as the “Company”, is a clinical-stage …See details»
Forte Biosciences - Overview, News & Similar companies - ZoomInfo
May 17, 2024 Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update DALLAS--(BUSINESS WIRE)--Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: …See details»
Forte Biosciences - VentureRadar
"Forte Biosciences, Inc. is a clinical stage, dermatology company developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases.See details»
Forte Biosciences, Inc. (FBRX) - Yahoo Finance
See the company profile for Forte Biosciences, Inc. (FBRX) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Dr. Scott Brun, M.D. Appointed to Forte Biosciences Board of …
Nov 14, 2022 Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), announced today that Dr. Scott Brun, M.D. has been appointed to the Forte Biosciences BoaSee details»
Forte Biosciences Inc - About Us
[email protected]. Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, …See details»
Forte Biosciences Inc - Dr. Scott Brun, M.D. Appointed to Forte ...
Nov 14, 2022 -Forte Leadership is Significantly Strengthened with the Appointment of Dr. Scott Brun, M.D. to the Board of Directors Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: …See details»
Forte BioSciences Inc Company Profile & Introduction - Tiger Brokers
Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such …See details»
Forte Biosciences Inc. - Cruelty Free Investing
Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on its lead product candidate, FB-401, which is a topical live biotherapeutic for the treatment of …See details»
ForteBio, Inc - VentureRadar
Protea Biosciences Group USA n/a Protea Biosciences is an innovative bioanalytics technology organization offering Mass Spectrometry Imaging and LC-MS services focused on protein …See details»
Forte Biosciences, Inc. (FBRX) Stock Price, News, Quote & History ...
Www.fortebiorx.com . 14. Full Time Employees. December 31. Fiscal Year Ends. Healthcare. Sector. Biotechnology. Industry. More about Forte Biosciences, Inc. Recent News: FBRX View …See details»
Forte Biosciences Inc - Forte Biosciences, Inc. Announces First …
May 16, 2022 - Forte Biosciences to Develop Novel Pipeline for the Treatment of Autoimmune Diseases - -Leadership Strengthened with Appointments of Stephen Doberstein, Ph.D. and …See details»
Forte Biosciences, Inc. Announces First Quarter 2022 Results and ...
May 16, 2022 Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases, today announced first quarterSee details»
Forte Biosciences, Inc. Announces First Quarter 2021 Results and ...
May 10, 2021 Forte Biosciences, Inc. Paul Wagner, CEO [email protected] LifeSci Advisors Mike Moyer, Managing Director 617.308.4306 [email protected] ContactsSee details»
Forte Biosciences Inc - Investor Relations
Apr 4, 2025 [email protected]. Email Alerts. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting …See details»
Forte Biosciences Inc - Forte Biosciences, Inc. Announces Second ...
Aug 15, 2022 -Forte Biosciences is Developing a Novel Pipeline for the Treatment of Autoimmune Diseases- -Leadership Strengthened with Appointments of Hubert Chen, M.D. as …See details»
Forte Biosciences, Inc. Announces 4Q and Full Year 2020 Results …
Mar 24, 2021 Forte Biosciences, Inc. Paul Wagner, CEO [email protected] LifeSci Advisors Mike Moyer, Managing Director 617.308.4306 [email protected] ContactsSee details»